Innovative Service Model Paragon Biomedical, now part of Clinipace Worldwide, has pioneered a digital clinical research model powered by its proprietary TEMPO™ platform, enabling efficient and accelerated drug and medical device development. This positions the company as a valuable partner for clients seeking modernized, technology-driven clinical trials.

Therapeutic Expertise With extensive experience across a broad range of therapeutic areas including cardiovascular, oncology, neurology, and immunology, Clinipace can effectively support pharmaceutical and biotech firms targeting diverse disease markets, creating cross-selling opportunities within those specializations.

Global Presence and Growth Headquartered in North Carolina with multiple regional offices worldwide, Clinipace’s global footprint allows it to serve multinational clients and expand into emerging markets, making it an attractive partner for companies looking to conduct international clinical trials.

Sustainable Funding & Recognition Having raised over 26 million dollars in funding and receiving recognition from Forbes and Inc. 500 lists, Clinipace demonstrates financial stability and industry credibility, which can reassure prospective clients and partners about their capacity to support large-scale, long-term research projects.

Leadership & Strategic Moves Recent leadership appointments and strategic partnerships like Virgo LLC indicate a focus on expanding operational capabilities and customer base, presenting sales opportunities with companies seeking innovative collaborations and tailored clinical research solutions to accelerate their product pipelines.